DB12362ApprovedWithdrawnSmall molecule
Diaminohydroxypropanetetraacetic acid has been investigated for the treatment of Vascular Disease, Coronary Disease, Myocardial Ischemia, Coronary Restenosis, and Coronary Artery Disease, among others.
- Mechanism
- Curator reviewed
Pharmacologically active on Presenilin-1
- Formula / weight
- C11H18N2O9 · 322.27 g/mol (avg)
- Also known as
- DAPT · Diaminohydroxypropanetetraacetic acid
- Code names
- NSC-59816
Resolves to
Clinical / RWD
Structure
InChIKey
WYMDDFRYORANCC-UHFFFAOYSA-NSMILESOC(CN(CC(O)=O)CC(O)=O)CN(CC(O)=O)CC(O)=OTargets
What you can answer from here — as of July 07, 2026
1Protein targetEach mapped to UniProt, with action and pharmacological actionListed above
Which drugs share a target with Diaminopropanol tetraacetic acid, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account